Michel Muálem de Moraes Alves

6PUBLICATIONS
46CO-AUTHORS
BiomaterialsCharacterisation of biological macromoleculesPredictive and prognostic markersBiologically active moleculesGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 23, 2026
Correction: Amphotericin B-Loaded Bigel: Characterization and in vivo Antileishmanial Evaluation in BALB/c Mice Infected with Leishmania amazonensis.

Rosilene Ribeiro de Sousa, Matheus Oliveira do Nascimento, Leandro Josuel da Costa Santos

|Jan 08, 2026
Amphotericin B-Loaded Bigel: Characterization and in vivo Antileishmanial Evaluation in BALB/c Mice Infected with Leishmania amazonensis.

Rosilene Ribeiro de Sousa, Matheus Oliveira do Nascimento, Leandro Josuel da Costa Santos

|Oct 22, 2025
Antileishmanial Activity of Oseltamivir and Acyclovir: Modulation of Macrophage Phagocytosis and Cytotoxicity Assessment.

Pastora P Lima Neta, Paulline P M S Leal, Victória Hannah A A Passos

|May 19, 2025
Toxicological safety, antioxidant effect, and chemoprotection determination of an extract from the babassu mesocarp (Orbignya phalerata Mart.) in preclinical studies.

Nicole Debia, Ana Beatriz Santana Sousa, Beatriz Arêa Cassiano de Melo

|Jul 13, 2022
Samanea tubulosa Benth. (Fabaceae): Antinociceptive effect on acute pain in mice: K+ATP channel and opioid activity.

Tamnata F Alixandre, Renato P Sousa, Bruno S Gomes

|Sep 15, 2020
Gallic and Ellagic Acids Are Promising Adjuvants to Conventional Amphotericin B for the Treatment of Cutaneous Leishmaniasis.

Michel Muálem de Moraes Alves, Daniel Dias Rufino Arcanjo, Kayo Alves Figueiredo

Pageof 1